You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ESA intolerant

Showing 1 - 25 of 628
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

MDS Trial in Beijing (Roxadustat, Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 17, 2023

Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)

Recruiting
  • Anemia
  • Ferric Derisomaltose Injection
  • Darbepoetin Alfa Injection
  • Anyang-si, Korea, Republic of
    Hallym University Medical Center
Mar 13, 2023

Erythropoiesis Stimulating Agents for Anemia Management in

Completed
  • Anemia of Chronic Kidney Disease
  • +2 more
    • Giza, Egypt
      the Memorial Souad Kafafi University Hospital
    Jan 24, 2023

    PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

    Not yet recruiting
    • PCNSL
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Jun 8, 2023

    MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Luspatercept
    • Epoetin Alfa
    • Concord, California
    • +100 more
    Jul 20, 2023

    Hypercholesterolemia Trial in Japan (K-877 0.2 mg/day (once daily), K-877 0.4 mg/day (once daily), Placebo (once daily))

    Recruiting
    • Hypercholesterolemia
    • K-877 0.2 mg/day (once daily)
    • +2 more
    • Aichi, Japan
    • +14 more
    Jun 20, 2023

    Anemia Trial in Worldwide (Vadadustat, Darbepoetin alfa)

    Completed
    • Anemia
    • Chula Vista, California
    • +58 more
    Nov 10, 2022

    Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical

    Completed
    • Hemodialysis-Associated Pruritus
    • +4 more
    • Dialysis using the Theranova-400 device.
    • Dialysis using the FX80 device.
    • Şanlıurfa, Karaköprü, Turkey
      Mehmet Akif Inan Training and Research Hospital
    Jan 13, 2023

    MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

    Recruiting
    • Myelodysplastic Syndromes
    • Canakinumab Injection
    • Darbepoetin Alfa
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 21, 2022

    Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)

    Suspended
    • Anemia of Chronic Kidney Disease
    • Hackensack, New Jersey
      Research Site
    Aug 23, 2022

    Anemia Associated With Chronic Kidney Disease Trial in United States (Roxadustat)

    Withdrawn
    • Anemia Associated With Chronic Kidney Disease
    • Chicago, Illinois
    • +3 more
    Jun 29, 2022

    Anemia of Chronic Kidney Disease Trial in Hackensack (vadadustat)

    Suspended
    • Anemia of Chronic Kidney Disease
    • Hackensack, New Jersey
      Research Site
    Aug 23, 2022

    MDS, MDS Trial in France (Luspatercept Injection [Reblozyl], Eprex)

    Recruiting
    • MDS
    • Myelodysplastic Syndromes
    • Luspatercept Injection [Reblozyl]
    • Eprex
    • Amiens, France
    • +30 more
    May 19, 2022

    Heart Failure Trial (Finerenone, Placebo)

    Not yet recruiting
    • Heart Failure
    • (no location specified)
    Sep 11, 2023

    Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

    Recruiting
    • Polycythemia Vera
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    May 19, 2023

    Metastatic Colorectal Cancer Trial in Nanjing (Envafolimab, Trifluridine/Tipiracil, Bevacizumab)

    Recruiting
    • Metastatic Colorectal Cancer
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Sep 24, 2023

    Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 12, 2023

    Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

    Recruiting
    • Healthy (For Part A)
    • Chronic Myeloid Leukemia (for Part B and C)
    • Vodobatinib (K0706) capsules
    • Downey, California
    • +69 more
    Dec 7, 2022

    Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

    Recruiting
    • Anemia in Dialysis-dependent CKD Patients
    • Alexandria, Egypt
      Alexandria University
    Oct 29, 2023

    Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Neuroendocrine Carcinoma
    • ZG006
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Aug 6, 2023

    Advanced Solid Tumor Trial in Beijing (SY-3505)

    Recruiting
    • Advanced Solid Tumor
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Sep 15, 2023

    Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

    Active, not recruiting
    • Myelofibrosis
    • Chronic Myelomonocytic Leukemia
    • Duarte, California
    • +9 more
    Jan 24, 2023

    Renal Insufficiency, Chronic Trial in France (Reticera)

    Terminated
    • Renal Insufficiency, Chronic
    • Reticera
    • Angers, France
    • +8 more
    Mar 3, 2022

    Solid Tumor, Breast Cancer, Pancreatic Cancer Trial in United States (SON-DP)

    Recruiting
    • Solid Tumor
    • +4 more
    • Gilbert, Arizona
    • +4 more
    Aug 4, 2023